These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1144 related articles for article (PubMed ID: 29025426)

  • 1. The complete European guidelines on phenylketonuria: diagnosis and treatment.
    van Wegberg AMJ; MacDonald A; Ahring K; Bélanger-Quintana A; Blau N; Bosch AM; Burlina A; Campistol J; Feillet F; Giżewska M; Huijbregts SC; Kearney S; Leuzzi V; Maillot F; Muntau AC; van Rijn M; Trefz F; Walter JH; van Spronsen FJ
    Orphanet J Rare Dis; 2017 Oct; 12(1):162. PubMed ID: 29025426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Key European guidelines for the diagnosis and management of patients with phenylketonuria.
    van Spronsen FJ; van Wegberg AM; Ahring K; Bélanger-Quintana A; Blau N; Bosch AM; Burlina A; Campistol J; Feillet F; Giżewska M; Huijbregts SC; Kearney S; Leuzzi V; Maillot F; Muntau AC; Trefz FK; van Rijn M; Walter JH; MacDonald A
    Lancet Diabetes Endocrinol; 2017 Sep; 5(9):743-756. PubMed ID: 28082082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similarities and differences in key diagnosis, treatment, and management approaches for PAH deficiency in the United States and Europe.
    Lowe TB; DeLuca J; Arnold GL
    Orphanet J Rare Dis; 2020 Sep; 15(1):266. PubMed ID: 32977849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PKU dietary handbook to accompany PKU guidelines.
    MacDonald A; van Wegberg AMJ; Ahring K; Beblo S; Bélanger-Quintana A; Burlina A; Campistol J; Coşkun T; Feillet F; Giżewska M; Huijbregts SC; Leuzzi V; Maillot F; Muntau AC; Rocha JC; Romani C; Trefz F; van Spronsen FJ
    Orphanet J Rare Dis; 2020 Jun; 15(1):171. PubMed ID: 32605583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic etiology and clinical challenges of phenylketonuria.
    Elhawary NA; AlJahdali IA; Abumansour IS; Elhawary EN; Gaboon N; Dandini M; Madkhali A; Alosaimi W; Alzahrani A; Aljohani F; Melibary EM; Kensara OA
    Hum Genomics; 2022 Jul; 16(1):22. PubMed ID: 35854334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The management of phenylketonuria in adult patients in Italy: a survey of six specialist metabolic centers.
    Burlina A; Leuzzi V; Spada M; Carbone MT; Paci S; Tummolo A
    Curr Med Res Opin; 2021 Mar; 37(3):411-421. PubMed ID: 33222540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of phenylketonuria in Europe: survey results from 19 countries.
    Blau N; Bélanger-Quintana A; Demirkol M; Feillet F; Giovannini M; MacDonald A; Trefz FK; van Spronsen F;
    Mol Genet Metab; 2010 Feb; 99(2):109-15. PubMed ID: 19800826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenylketonuria Scientific Review Conference: state of the science and future research needs.
    Camp KM; Parisi MA; Acosta PB; Berry GT; Bilder DA; Blau N; Bodamer OA; Brosco JP; Brown CS; Burlina AB; Burton BK; Chang CS; Coates PM; Cunningham AC; Dobrowolski SF; Ferguson JH; Franklin TD; Frazier DM; Grange DK; Greene CL; Groft SC; Harding CO; Howell RR; Huntington KL; Hyatt-Knorr HD; Jevaji IP; Levy HL; Lichter-Konecki U; Lindegren ML; Lloyd-Puryear MA; Matalon K; MacDonald A; McPheeters ML; Mitchell JJ; Mofidi S; Moseley KD; Mueller CM; Mulberg AE; Nerurkar LS; Ogata BN; Pariser AR; Prasad S; Pridjian G; Rasmussen SA; Reddy UM; Rohr FJ; Singh RH; Sirrs SM; Stremer SE; Tagle DA; Thompson SM; Urv TK; Utz JR; van Spronsen F; Vockley J; Waisbren SE; Weglicki LS; White DA; Whitley CB; Wilfond BS; Yannicelli S; Young JM
    Mol Genet Metab; 2014 Jun; 112(2):87-122. PubMed ID: 24667081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The European Phenylketonuria Guidelines and the challenges on management practices in Portugal.
    Sousa C; Almeida MF; Sousa Barbosa C; Martins E; Janeiro P; Tavares de Almeida I; MacDonald A; Rocha JC
    J Pediatr Endocrinol Metab; 2019 Jun; 32(6):623-629. PubMed ID: 31141484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations on phenylketonuria in Turkey.
    Coşkun T; Çoker M; Mungan NÖ; Özel HG; Sivri HS
    Turk J Pediatr; 2022; 64(3):413-434. PubMed ID: 35899555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and management practices for phenylketonuria in 19 countries of the South and Eastern European Region: survey results.
    Giżewska M; MacDonald A; Bélanger-Quintana A; Burlina A; Cleary M; Coşkun T; Feillet F; Muntau AC; Trefz FK; van Spronsen FJ; Blau N
    Eur J Pediatr; 2016 Feb; 175(2):261-72. PubMed ID: 26350228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-year retrospective analysis of patients with phenylketonuria (PKU) and hyperphenylalaninemia treated at two specialized clinics.
    Levy H; Lamppu D; Anastosoaie V; Baker JL; DiBona K; Hawthorne S; Lindenberger J; Kinch D; Seymour A; McIlduff M; Watling S; Vockley J
    Mol Genet Metab; 2020 Mar; 129(3):177-185. PubMed ID: 31883647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guide for diagnosis and treatment of hyperphenylalaninemia.
    Shintaku H; Ohura T; Takayanagi M; Kure S; Owada M; Matsubara Y; Yoshino M; Okano Y; Ito T; Okuyama T; Nakamura K; Matuo M; Endo F; Ida H
    Pediatr Int; 2021 Jan; 63(1):8-12. PubMed ID: 33423362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPLC for confirmatory diagnosis and biochemical monitoring of Cuban patients with hyperphenylalaninemias.
    Contreras J; Alonso E; Fuentes LE
    MEDICC Rev; 2015 Jan; 17(1):23-8. PubMed ID: 25725765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenylalanine hydroxylase deficiency.
    Mitchell JJ; Trakadis YJ; Scriver CR
    Genet Med; 2011 Aug; 13(8):697-707. PubMed ID: 21555948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenylketonuria: screening, treatment and maternal PKU.
    Matalon R; Michals K
    Clin Biochem; 1991 Aug; 24(4):337-42. PubMed ID: 1959225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International best practice for the evaluation of responsiveness to sapropterin dihydrochloride in patients with phenylketonuria.
    Muntau AC; Adams DJ; Bélanger-Quintana A; Bushueva TV; Cerone R; Chien YH; Chiesa A; Coşkun T; de Las Heras J; Feillet F; Katz R; Lagler F; Piazzon F; Rohr F; van Spronsen FJ; Vargas P; Wilcox G; Bhattacharya K
    Mol Genet Metab; 2019 May; 127(1):1-11. PubMed ID: 31103398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PAH gene, phenylketonuria, and a paradigm shift.
    Scriver CR
    Hum Mutat; 2007 Sep; 28(9):831-45. PubMed ID: 17443661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Italian national consensus statement on management and pharmacological treatment of phenylketonuria.
    Burlina A; Biasucci G; Carbone MT; Cazzorla C; Paci S; Pochiero F; Spada M; Tummolo A; Zuvadelli J; Leuzzi V
    Orphanet J Rare Dis; 2021 Nov; 16(1):476. PubMed ID: 34784942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic Control of Patients with Phenylketonuria in a Portuguese Metabolic Centre Comparing Three Different Recommendations.
    Kanufre V; Almeida MF; Barbosa CS; Carmona C; Bandeira A; Martins E; Rocha S; Guimas A; Ribeiro R; MacDonald A; Pinto A; Rocha JC
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34578995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.